As depicted in Fig. 6d, our results revealed an inverse correlation between STAT1 overexpression in glioma cells and the p53 pathway, which has been identified as a beneficial factor for enhancing the overall outlook of patients with glioma [23]. Here, TP53 is linked to central nervous system cancer.